SBIR/STTR Research Award
RAPID POINT OF CARE MOLECULAR DIAGNOSTICS FOR HCV
Award amount
$299,957Program and phase
SBIR · Phase IAward year
2021Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PHOENIX BIOSYSTEM, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NXDUD4NDDQ93
- Solicitation number
- PHS2021-1
- Topic code
- 99
Research abstract
To develop rapid, point-of-care diagnostics for Hepatitis C Virus (HCV).
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- HPV POINT OF CARE MOLECULAR DIAGNOSTICS FOR LMICS
- Low cost, automated smartphone based assay for semen analysis
- Rapid Nucleic Acid Test for Chlamydia in Resource Limited Settings
- POINT OF CARE HIV COMBO ASSAY
- Multiplexed Point Of Care Nucleic Acid Assay for STI
Research funding history
27 SBIR/STTR records share this UEI (2002–2022). Reported award amounts total $7,473,973. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation, Department of Energy